As Hemmi notes: Some people will lose access. In an emailed statement to WIRED, a spokesperson for Novo Nordisk says, Moving forward, any compounder that mass produces or sells knockoff drugs is breaking the law and compromising patient safety. A spokesperson for Eli Lilly echoed that sentiment, saying via email that the FDA and a federal court have both made clear that compounders must cease production of compounded tirzepatide knockoffs. Anthony Comuzzie, CEO of the Obesity Society, recognizes that there are legitimate access issues to GLP-1 medications, but he worries that some people who have sought out compounded versions may not meet the medical definition of obesity and are using them more casually for weight loss
Perimenopause and Hormonal Changes Thats right: the big M could be behind missed periods on GLP-1s
On top of ethical drugs, everything in our store is a healthy lifestyle product or service
Many patients see the best results when semaglutide GLP-1 is combined with realistic lifestyle changes, such as eating balanced meals, focusing on protein, limiting processed foods, staying hydrated, and adding regular movement